Clinical trial
Autologous Cytokine-induced Killer Cell Adoptive Immunotherapy for Acute Myeloid…
NCT00394381 · Singapore General Hospital, Other · Completed
Key facts
| NCT number | NCT00394381 |
|---|---|
| Title | Autologous Cytokine-induced Killer Cell Adoptive Immunotherapy for Acute Myeloid Leukemia and Myelodysplastic Syndrome |
| Official title | Autologous Cytokine-induced Killer Cell Adoptive Immunotherapy for Acute Myeloid Leukemia and Myelodysplastic Syndrome |
| Lead sponsor | Singapore General Hospital, Other |
| Collaborators | National Medical Research Council (NMRC), Singapore |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Acute Myeloid Leukemia, Myelodysplastic Syndrome, High Grade |
| Intervention type | Procedure |
| Interventions | Infusion of autologous CIK cells |
| Enrollment | 17 |
| Start date | Oct 1, 2006 |
| Primary completion | Jan 1, 2012 |
| Completion | Jan 1, 2012 |
| First posted | Nov 1, 2006 |
| Last update posted | Feb 10, 2017 |
| Countries | Singapore |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: